Blog
We are thrilled to be the first laboratory to launch cc. It will be available on November 4th, 2024, and is designed to enhance your experience, meet your needs, and keep you ahead of the curve!
Click here to learn more about our state-of-the-art SSRI testing in umbilical cord tissue that identifies in-utero exposure to help your hospital provide appropriate attention in the crucial first days of life.
USDTL Forensic Blog
- Umbilical Cord Tissue Testing for SSRIs
- A Comparison of Turnaround-Times for Two Popular Specimen Types Used for Newborn Toxicology: Meconium and Umbilical Cord Tissue
- Using Umbilical Cord Tissue to Identify Prenatal Ethanol Exposure and Co-exposure to Other Commonly Misused Substances
- Toxicology as a Diagnostic Tool to Identify the Misuse of Drugs in the Perinatal Period
- Specimen Delay
- Drug Classes and Neurotransmitters: Amphetamine, Cocaine, and Hallucinogens
- Environmental Exposure Testing for Delta-8 THC, Delta-9 THC, Delta-10 THC, and CBD
- Bromazolam and Synthetic Benzodiazepines
- October 2024 (5)
- March 2024 (1)
- February 2024 (1)
- January 2024 (3)
- December 2023 (1)
- November 2023 (1)
adult and child
adult and child drug testing
alcohol biomarker
alcohol testing
alcohol use
answer key
barbiturates
bath salts
cannabidiol
cannabinoids
cbd
Chicago
child hair testing
CLMA
diazepam
direct biomarker
drug abuse
drug exposure
drug ingestion
drugs in fingernail
drug testing
EtG
ethyl glucuronide
FAS
FASD
fentanyl
Forensic Drug Testing
Forensic Technology
forensic toxicology
gabapentin
hair testing
heroin
Inc.
Innovation
ISO/IEC 17025
K2
legalization
marijuana
NAS
neontal drug exposure
newborn
newborn drug testing
opiates
opioid crisis
opioids
PEth biomarker
Phosphatidylethanol
Pilkington
sedatives
spice
synthetic cannabinoids
synthetic drug
teens
thc
toxicology
tramadol
umbilical cord
umbilical cord testing
umbilical cord tissue
umbilical cord tissue testing
United States Drug Testing Laboratories
United States Drug Testing Laboratories Inc.
USDTL
zolpidem
